HistologiX is a trusted GLP & GCP compliant CRO for tissue-based analysis – make the most of our expertise.

We help you visualise and understand what your drug or device is doing to your key biomarkers at the cellular and tissue level. Working collaboratively, our experienced scientific team provides a bespoke service allowing you to make the most of our expertise in histology, immunohistochemistry (IHC) including multiplex immunofluorescence (IF), In Situ Hybridisation (ISH) using RNAScope & cutting-edge digital image analysis using Visiopharm.

Our scientific experts will develop, optimise and validate biomarker targets for use in distribution, proof of concept, mechanism of action studies using immunohistochemistry and fluorescence endpoints.

We offer antibody cross-reactivity (TCR) testing, antibody screening, histology, and immunohistochemistry services, including ISH (automated RNAscope), whole slide digital scanning and image analysis (Visiopharm software), Veterinary and Medical Pathologist evaluation from discovery, preclinical through to clinical drug development.

Our GCP Clinical Trial Support team has expertise in tissue handling protocols, patient stratification and evaluation of digital pathology end points including analysis of the tumour microenvironment.

For each project, our experienced scientists work as an extension of your in-house team to define your bespoke project requirements and customise the study plan to ensure you get the results you need. We provide an excellent quality technical service supporting biomarker evaluation of cutting-edge therapeutics including cell and gene therapies, oncolytic viruses, therapeutic antibodies, small molecules, and RNA modifying enzymes.